Amyotrophic Lateral Sclerosis Association (ALSA) Certified Treatment Center of Excellence
The ALS Program at Cedars-Sinai is the first in Southern California to be named an ALS Association Certified Treatment Center of Excellence – a distinction that recognizes the quality of its treatment and research programs for patients with amyotrophic lateral sclerosis (Lou Gehrig's disease).
To earn certification, Cedars-Sinai met rigorous standards established by The ALS Association for research initiatives and a comprehensive and collaborative approach to patient care and services.
Charcot-Marie-Tooth Association Center of Excellence
Cedars-Sinai is one of the CMT Association's 16 Centers of Excellence, and the only one located in Southern California. The designation is indicative of the Charcot-Marie-Tooth/Hereditary Neuropathy Center's dedication to patient-centric, multidisciplinary care. Charcot-Marie-Tooth, the most common inherited neurological disorder, damages nerves that control muscles, primarily affecting the legs and feet.
Guillain-Barré Syndrome/Chronic Inflammatory Demyelinating Polyneuropathy Foundation International Center of Excellence
Cedars-Sinai has earned designation as one GBS/CIDP Foundation International's 18 Centers of Excellence worldwide. The certification is earned based on levels of expertise, available treatments, facilities and research capabilities.
Guillain-Barré syndrome is an acute inflammatory disorder of nerves outside the brain and spinal cord that can lead to paralysis. Despite severe weakness, most patients have a good recovery. CIDP can be considered a chronic form of GBS. It also attacks the peripheral nerves and is believed to have an autoimmune basis, but symptom onset is gradual and the disease is progressive or relapsing, extending over several years.